Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
SkyePharma
SkyePharma
Activities:
Manufacturing
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Drug Delivery
SkyePharma signs exclusive licensing agreement to access Lucideon’s abuse deterrent drug delivery technology
First product to be developed for the growing $11bn US opioid market
Manufacturing
Skyepharma installs MG2 Planeta
To address its needs for the production of pilot and clinical batches of inhalation products and third party projects
Research & Development
David Lescuyer joins SkyePharma as Executive Vice President, Oral Business
He will be responsible for Skyepharma’s Oral Business including, after 30 June, the manufacturing operations in Saint-Quentin Fallavier, France
Finance
Vectura and Skyepharma agree to merge
Respiratory drug delivery specialists will become an industry-leading airways-related speciality business
Research & Development
Skyepharma acquires novel inhaled therapy platform
New product opportunity to be developed as an anti-inflammatory treatment for COPD
Drug Delivery
Flutiform sales drive growth at SkyePharma
Plans to raise £112m in capital to pay off bond debt and strengthen product pipeline
Drug Delivery
SkyePharma reports strong revenue growth
Underpinned by sales of Flutiform and use of proprietary dry powder formulation technology in GSK product
Subscribe now